World´s leading experts gather in Seville to discuss the fastest growing health epidemic in Europe now affecting 1 in 4 people. 26 September 2019 – Seville, Spain The Non-Alcoholic Fatty Liver Disease prevalence in Europe is a preventable epidemic, leading…
Modules 3 and 4 of the EASL/EFSUMB Ultrasound of the Liver course are now available on EASL Campus. Module 3 – Focal liver lesions; the liver and biliary system Course description: The third module of the EASL/EFSUMB Basics of Ultrasound…
EASL’s goal is to pursue and facilitate excellence in liver research, clinical practice of liver disorders, and the provision of education to all those interested in hepatology. This requires recognizing and supporting excellence regardless of gender, ethnicity, nationality, disability, religion,…
The HCC: Management of the side effects of immune checkpoint inhibitors course* is now available on EASL Campus. Course description : In this fascinating discussion, four of the leading experts in the field of hepatocellular carcinoma (HCC) discuss the use of…
The Lancet-EASL Commission is tackling liver diseases in Europe and overcoming unmet needs, stigma and inequities. The Commission is quantifying the burden of liver disease in Europe and addressing optimal diagnosis and standards of care for patients with liver diseases…
EASL, the European Association for the Study of the Liver, is now calling for nominations for a new Scientific Committee member to join the Governing Board for a 3 year term starting in April 2020. European National Associations are invited…
Call for schools 2021 EASL would like to provide its members with the ability to participate by opening a call for programme outline proposals and proposed topics. In 2021, EASL plans to present two clinical and one basic school, to…
Professor Paolo Angeli has been elected Editor-in-Chief of the Journal of Hepatology – the flagship journal of the European Association for the Study of the Liver (EASL) Prof. Paolo Angeli was selected by the EASL Governing Board, with his appointment…
Starting September 2019 Hainsworth will serve as the interface between the EASL Governing Board and the organisation`s Geneva and Brussels operations, ensuring high quality and effective implementation of the Governing Board`s policies and decisions. Hainsworth has worked for 25 years…
GENEVA, Switzerland Last week, ClarivateTM Analytics released the 2019 update of its Journal Citation Reports©, including the much anticipated 2018 impact factor. EASL’s flagship monthly journal, the Journal of Hepatology achieved unprecedented results with a 2018 impact factor of 18.946,…